Therapeutic response of multidrug-resistant Plasmodium falciparum and P. vivax to chloroquine and sulfadoxine–pyrimethamine in southern Papua, Indonesia
2006

Drug Resistance in Malaria Treatment in Papua, Indonesia

Sample size: 143 publication Evidence: high

Author Information

Author(s): Ratcliff A., Siswantoro H., Kenangalem E., Wuwung M., Brockman A., Edstein M.D., Laihad F., Ebsworth E.P., Anstey N.M., Tjitra E., Price R.N.

Primary Institution: Menzies School of Health Research and Charles Darwin University

Hypothesis

What is the level of antimalarial drug resistance in southern Papua, Indonesia?

Conclusion

The study found a high prevalence of drug resistance in both Plasmodium falciparum and P. vivax, leading to significant treatment failures.

Supporting Evidence

  • Early treatment failures occurred in 4% of patients with P. falciparum and 15% with P. vivax.
  • The failure rate by Day 28 for P. vivax was 65%.
  • Re-treatment with unsupervised quinine resulted in further recurrence of malaria in 48% of P. falciparum infections.
  • High prevalence of drug resistance exists for both P. falciparum and P. vivax.

Takeaway

In Papua, the medicines used to treat malaria are not working well anymore, especially for two types of malaria called P. falciparum and P. vivax.

Methodology

This was a prospective, open-label drug efficacy study assessing the therapeutic efficacy of chloroquine plus sulfadoxine–pyrimethamine for P. falciparum and chloroquine for P. vivax.

Potential Biases

Potential bias due to the open-label design and the reliance on patient self-reporting for follow-up.

Limitations

The study was limited by the high rates of treatment failure and the inability to continue the study due to ethical concerns.

Participant Demographics

{"age":{"median":16,"range":"1-60"},"gender":{"male_percentage":61,"female_percentage":39},"ethnicity":{"Papuan":57}}

Statistical Information

Confidence Interval

{"failure_rate_p_vivax":"95% CI 49–81","failure_rate_p_falciparum":"95% CI 31–65"}

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1016/j.trstmh.2006.06.008

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication